{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:46:40Z","timestamp":1773780400168,"version":"3.50.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Stanton Foundation Spectrum of Care Clinical Research Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Desoxycorticosterone pivalate (DOCP) is commonly used to treat mineralocorticoid deficiency in dogs with hypoadrenocorticism (HA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objective<\/jats:title>\n                    <jats:p>To determine the pharmacokinetics and pharmacodynamics of DOCP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Twenty-one dogs with newly diagnosed HA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective clinical trial. Dogs were randomly assigned to treatment with an SC injection of either 1.1\u00a0mg\/kg (low-dose) or 2.2\u00a0mg\/kg (label-dose) DOCP. Blood samples were collected at set time points for measurement of serum drug concentrations, serum electrolyte concentrations, and plasma renin activities (PRAs). A one-compartment model was used to determine pharmacokinetics variables. Pharmacodynamics variables including duration of DOCP action and duration of overtreatment were estimated from serum electrolyte concentrations and PRA. Pharmacokinetics and pharmacodynamics variables were compared between low-dose and label-dose groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Maximum drug concentrations and overall drug exposures were higher in label-dose dogs (1.22\u00a0\u00b1\u00a00.46\u00a0ng\/mL and 32.1\u00a0\u00b1\u00a012.3\u00a0day\u00a0\u00d7\u00a0ng\/mL) than in low-dose dogs (0.69\u00a0\u00b1\u00a00.32\u00a0ng\/mL and 19.6\u00a0\u00b1\u00a05.3\u00a0day\u00a0\u00d7\u00a0ng\/mL; P\u00a0=\u00a0.008 for both comparisons). However, duration of DOCP action as determined by PRA in label-dose (55\u00a0\u00b1\u00a016\u00a0days) and low-dose (45\u00a0\u00b1\u00a012\u00a0days) dogs was not different (P\u00a0=\u00a0.2). Serum electrolyte concentrations overestimated the duration of action in the combined group by a mean of 10\u00a0days when compared with PRA (P\u00a0&amp;lt;\u00a0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and clinical importance<\/jats:title>\n                    <jats:p>Pharmacokinetics and pharmacodynamics data suggest that low-dose DOCP administered every 5-7\u00a0weeks is a reasonable treatment strategy for most dogs with HA. Prolonging dosing intervals &amp;gt;\u20097-8\u00a0weeks based solely on electrolyte concentrations should be avoided.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jvimsj\/aalaf003","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:01:47Z","timestamp":1768986107000},"source":"Crossref","is-referenced-by-count":0,"title":["Pharmacokinetics and pharmacodynamics of desoxycorticosterone pivalate in dogs with hypoadrenocorticism"],"prefix":"10.1093","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7726-6307","authenticated-orcid":false,"given":"Daniel K","family":"Langlois","sequence":"first","affiliation":[{"name":"Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University , East Lansing, MI 48824 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Dirikolu","sequence":"additional","affiliation":[{"name":"Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University , Baton Rouge, LA 70803 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean M","family":"Brudvig","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University , East Lansing, MI 48910 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas F","family":"Lehner","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University , East Lansing, MI 48910 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie L","family":"Nelms","sequence":"additional","affiliation":[{"name":"Greater Lansing Veterinary Center , Williamston, MI 48895 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan A","family":"Carey","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University , East Lansing, MI 48824 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A","family":"Jablonski","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University , East Lansing, MI 48824 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Cridge","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University , East Lansing, MI 48824 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enass","family":"Bassiouny","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University , East Lansing, MI 48910 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Zyskowski","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University , East Lansing, MI 48910 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4077-5014","authenticated-orcid":false,"given":"John P","family":"Buchweitz","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University , East Lansing, MI 48910 ,","place":["United States"]},{"name":"Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University , East Lansing, MI 48824 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"2026031705571886900_ref1","first-page":"1825","volume-title":"Textbook of Veterinary Internal Medicine","author":"Hess","year":"2017","edition":"8th"},{"key":"2026031705571886900_ref2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2460\/javma.1996.208.01.85","article-title":"Pretreatment clinical and laboratory findings in dogs with hypoadrenocorticism: 225 cases (1979-1993)","volume":"208","author":"Peterson","year":"1996","journal-title":"J Am Vet Med Assoc"},{"key":"2026031705571886900_ref3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2460\/javma.1982.180.01.59","article-title":"Canine hypoadrenocorticism: report of 37 cases and review of 39 previously reported cases","volume":"180","author":"Willard","year":"1982","journal-title":"J Am Vet Med Assoc"},{"key":"2026031705571886900_ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143458","article-title":"Autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison\u2019s disease)","volume":"10","author":"Boag","year":"2015","journal-title":"PLoS One"},{"key":"2026031705571886900_ref5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1748-5827.2003.tb00096.x","article-title":"Heritability and complex segregation analysis of hypoadrenocorticism in the Standard Poodle","volume":"44","author":"Famula","year":"2003","journal-title":"J Small Anim Pract"},{"key":"2026031705571886900_ref6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/0300985816684914","article-title":"Lymphocyte subsets in the adrenal glands of dogs with hypoadrenocorticism","volume":"55","author":"Friedenberg","year":"2018","journal-title":"Vet Pathol"},{"key":"2026031705571886900_ref7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00251-019-01113-0","article-title":"DLA class II haplotypes show sex-specific associations with primary hypoadrenocorticism in Standard Poodle dogs","volume":"71","author":"Treeful","year":"2019","journal-title":"Immunogenetics"},{"key":"2026031705571886900_ref8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/jvim.12243","article-title":"Evaluation of aldosterone concentrations in dogs with hypoadrenocorticism","volume":"28","author":"Baumstark","year":"2014","journal-title":"J Vet Intern Med"},{"key":"2026031705571886900_ref9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1939-1676.1997.tb00072.x","article-title":"Treatment and long-term follow-up of 205 dogs with hypoadrenocorticism","volume":"11","author":"Kintzer","year":"1997","journal-title":"J Vet Intern Med"},{"key":"2026031705571886900_ref10","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2460\/javma.1993.202.03.392","article-title":"Efficacy of microcrystalline desoxycorticosterone pivalate for treatment of hypoadrenocorticism in dogs","volume":"202","author":"Lynn","year":"1993","journal-title":"J Am Vet Med Assoc"},{"key":"2026031705571886900_ref11","volume-title":"Package insert for Percorten-V\u00ae"},{"key":"2026031705571886900_ref12","volume-title":"Package insert for Zycortal\u00ae"},{"key":"2026031705571886900_ref13","doi-asserted-by":"publisher","DOI":"10.1136\/vr.105328","article-title":"Randomised clinical non-inferiority trial comparing two formulations of desoxycortone pivalate for the treatment of canine primary hypoadrenocorticism","volume":"187","author":"Farr","year":"2020","journal-title":"Vet Rec"},{"key":"2026031705571886900_ref14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/avj.12019","article-title":"Lower initial dose desoxycorticosterone pivalate for treatment of canine primary hypoadrenocorticism","volume":"91","author":"Bates","year":"2013","journal-title":"Aust Vet J"},{"key":"2026031705571886900_ref15","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1111\/jvim.14828","article-title":"Desoxycorticosterone pivalate duration of action and individualized dosing intervals in dogs with primary hypoadrenocorticism","volume":"31","author":"Jaffey","year":"2017","journal-title":"J Vet Intern Med"},{"key":"2026031705571886900_ref16","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/jvim.15475","article-title":"Evaluation of a low-dose desoxycorticosterone pivalate treatment protocol for long-term management of dogs with primary hypoadrenocorticism","volume":"33","author":"Sieber-Ruckstuhl","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026031705571886900_ref17","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1111\/jvim.16195","article-title":"Low-dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: a randomized controlled clinical trial","volume":"35","author":"Vincent","year":"2021","journal-title":"J Vet Intern Med"},{"key":"2026031705571886900_ref18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/vetsci8110271","article-title":"Use of deoxycorticosterone pivalate by veterinarians: a western European survey","volume":"8","author":"Rebocho","year":"2021","journal-title":"Vet Sci"},{"key":"2026031705571886900_ref19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye","year":"2021","journal-title":"Lancet"},{"key":"2026031705571886900_ref20","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae174","article-title":"Plasma renin, a useful marker for mineralocorticoid adjustments in patients with primary adrenal insufficiency","volume":"8","author":"Piazzola","year":"2024","journal-title":"J Endocr Soc"},{"key":"2026031705571886900_ref21","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/jvim.12426","article-title":"Use of plasma renin activity to monitor mineralocorticoid treatment in dogs with primary hypoadrenocorticism: desoxycorticosterone versus fludrocortisone","volume":"28","author":"Baumstark","year":"2014","journal-title":"J Vet Intern Med"},{"key":"2026031705571886900_ref22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12020-019-01974-1","article-title":"Plasma renin levels are associated with cardiac function in primary adrenal insufficiency","volume":"65","author":"Wolf","year":"2019","journal-title":"Endocrine"},{"key":"2026031705571886900_ref23","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/jvim.14589","article-title":"Evaluation of basal serum or plasma cortisol concentrations for the diagnosis of hypoadrenocorticism in dogs","volume":"30","author":"Gold","year":"2016","journal-title":"J Vet Intern Med"},{"key":"2026031705571886900_ref24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2460\/ajvr.1992.53.05.716","article-title":"Duration of pituitary and adrenocortical suppression after long-term administration of anti-inflammatory doses of prednisone in dogs","volume":"53","author":"Moore","year":"1992","journal-title":"Am J Vet Res"},{"key":"2026031705571886900_ref25","first-page":"407","article-title":"Ketoconazole-induced transient hypoadrenocorticism in a dog","volume":"61","author":"Sullivant","year":"2020","journal-title":"Can Vet J"},{"key":"2026031705571886900_ref26","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1177\/10406387211029247","article-title":"Validation study of canine serum cortisol measurement with the Immulite 2000 Xpi cortisol immunoassay","volume":"33","author":"Korchia","year":"2021","journal-title":"J Vet Diag Invest"},{"key":"2026031705571886900_ref27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/vcp.12006","article-title":"ASVCP reference interval guidelines: determination of de novo reference intervals in veterinary species and other related topics","volume":"41","author":"Friedrichs","year":"2012","journal-title":"Vet Clin Pathol"},{"key":"2026031705571886900_ref28","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/15376516.2025.2489026","article-title":"Development of mass spectrometric methods for determination of desoxycorticosterone pivalate and its esterase product in canine serum","volume":"35","author":"Lehner","year":"2025","journal-title":"Toxicol Mech Methods"},{"key":"2026031705571886900_ref29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1210\/jc.2017-01928","article-title":"Primary adrenal insufficiency: managing mineralocorticoid replacement therapy","volume":"103","author":"Espositio","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031705571886900_ref30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1055\/a-0804-2715","article-title":"An update on Addison\u2019s disease","volume":"127","author":"Barthel","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026031705571886900_ref31","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1210\/jc.2016-2221","article-title":"Exploring inpatient hospitalizations and morbidity in patients with adrenal insufficiency","volume":"101","author":"Stewart","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031705571886900_ref32","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison\u2019s disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031705571886900_ref33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.beem.2014.08.008","article-title":"Mineralocorticoid substitution and monitoring in primary adrenal insufficiency","volume":"29","author":"Quinkler","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026031705571886900_ref34","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031705571886900_ref35","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026031705571886900_ref36","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in left ventricular anatomy and function in hypertension and primary aldosteronism","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"key":"2026031705571886900_ref37","doi-asserted-by":"publisher","DOI":"10.1002\/vetr.242","article-title":"Evaluation of symmetric dimethylarginine and creatinine in dogs with primary hypoadrenocorticism receiving long-term mineralocorticoid replacement therapy","volume":"190","author":"Casado D\u00edaz","year":"2022","journal-title":"Vet Rec"},{"key":"2026031705571886900_ref38","first-page":"387","article-title":"Clinical features of hypoadrenocorticism in soft-coated wheaten terrier dogs: 82 cases (1979-2013)","volume":"57","author":"Haviland","year":"2016","journal-title":"Can Vet J"},{"key":"2026031705571886900_ref39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1258\/000456307780945624","article-title":"Liquorice and soy sauce, a life-saving concoction in a patient with Addison\u2019s disease","volume":"44","author":"Cooper","year":"2007","journal-title":"Ann Clin Biochem"},{"key":"2026031705571886900_ref40","first-page":"1411","article-title":"Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison\u2019s disease","volume":"81","author":"Cohen","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031705571886900_ref41","first-page":"259","article-title":"Diagnosis and therapy surveillance in Addison\u2019s disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone","volume":"75","author":"Oelkers","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031705571886900_ref42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0140-6736(84)90181-8","article-title":"Evidence that patients with Addison\u2019s disease are undertreated with fludrocortisone","volume":"1","author":"Smith","year":"1984","journal-title":"Lancet"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/40\/1\/aalaf003\/66458769\/aalaf003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/40\/1\/aalaf003\/66458769\/aalaf003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:29:23Z","timestamp":1773768563000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/doi\/10.1093\/jvimsj\/aalaf003\/8429730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jvimsj\/aalaf003","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"aalaf003"}}